CME Group (NASDAQ:CME) Price Target Cut to $225.00 by Analysts at Piper Sandler

CME Group (NASDAQ:CME) had its price objective lowered by Piper Sandler from $235.00 to $225.00 in a report published on Thursday, Benzinga reports. The brokerage currently has an overweight rating on the financial services provider’s stock.

Other equities research analysts also recently issued research reports about the company. Barclays reduced their target price on CME Group from $228.00 to $208.00 and set an equal weight rating on the stock in a report on Wednesday, July 10th. Keefe, Bruyette & Woods reaffirmed a market perform rating and issued a $226.00 target price on shares of CME Group in a report on Wednesday, July 3rd. Bank of America raised their target price on CME Group from $209.00 to $216.00 and gave the company a neutral rating in a report on Thursday, April 25th. Rosenblatt Securities reiterated a sell rating and issued a $187.00 price target (up from $185.00) on shares of CME Group in a research note on Thursday, April 25th. Finally, Morgan Stanley increased their price target on CME Group from $222.00 to $225.00 and gave the company an equal weight rating in a research note on Tuesday, April 9th. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of Hold and an average price target of $212.64.

CME Group Trading Up 0.6 %

Shares of NASDAQ:CME opened at $200.54 on Thursday. The company has a market capitalization of $72.21 billion, a P/E ratio of 22.81, a P/E/G ratio of 6.65 and a beta of 0.52. CME Group has a 1 year low of $190.70 and a 1 year high of $223.80. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.01. The business’s 50 day simple moving average is $199.87 and its 200 day simple moving average is $207.06.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company’s revenue was up 12.7% compared to the same quarter last year. During the same quarter last year, the business posted $2.30 EPS. On average, research analysts anticipate that CME Group will post 9.8 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Friday, June 7th were given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.29%. The ex-dividend date of this dividend was Friday, June 7th. CME Group’s dividend payout ratio is currently 52.33%.

Insider Buying and Selling

In related news, Director Charles P. Carey sold 3,000 shares of the firm’s stock in a transaction on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the completion of the transaction, the director now directly owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, insider Hilda Harris Piell sold 7,140 shares of CME Group stock in a transaction dated Wednesday, May 8th. The stock was sold at an average price of $210.35, for a total value of $1,501,899.00. Following the completion of the transaction, the insider now directly owns 29,256 shares of the company’s stock, valued at approximately $6,153,999.60. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the completion of the transaction, the director now directly owns 7,163 shares of the company’s stock, valued at $1,399,936.72. The disclosure for this sale can be found here. Insiders sold a total of 14,290 shares of company stock valued at $2,957,300 in the last three months. Insiders own 0.30% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in CME. CoreCap Advisors LLC bought a new position in shares of CME Group in the 4th quarter worth about $275,000. Pacer Advisors Inc. grew its stake in shares of CME Group by 76.2% in the 4th quarter. Pacer Advisors Inc. now owns 40,006 shares of the financial services provider’s stock valued at $8,425,000 after buying an additional 17,302 shares during the period. Planned Solutions Inc. acquired a new stake in shares of CME Group in the 4th quarter valued at about $63,000. Ritholtz Wealth Management grew its stake in shares of CME Group by 5.9% in the 4th quarter. Ritholtz Wealth Management now owns 6,099 shares of the financial services provider’s stock valued at $1,285,000 after buying an additional 340 shares during the period. Finally, Meadow Creek Wealth Advisors LLC acquired a new stake in shares of CME Group in the 4th quarter valued at about $594,000. 87.75% of the stock is owned by institutional investors.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.